| Product Code: ETC7913767 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Latvia Ischemic Stroke Market Overview |
3.1 Latvia Country Macro Economic Indicators |
3.2 Latvia Ischemic Stroke Market Revenues & Volume, 2021 & 2031F |
3.3 Latvia Ischemic Stroke Market - Industry Life Cycle |
3.4 Latvia Ischemic Stroke Market - Porter's Five Forces |
3.5 Latvia Ischemic Stroke Market Revenues & Volume Share, By Diagnosis, 2021 & 2031F |
3.6 Latvia Ischemic Stroke Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
4 Latvia Ischemic Stroke Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of risk factors such as hypertension, diabetes, and obesity in Latvia |
4.2.2 Advancements in medical technology and treatment options for ischemic stroke |
4.2.3 Government initiatives and healthcare reforms focusing on stroke prevention and management |
4.3 Market Restraints |
4.3.1 Limited access to specialized stroke treatment centers and healthcare facilities in rural areas |
4.3.2 High cost associated with advanced stroke treatments and therapies |
4.3.3 Lack of awareness and education among the population about the signs and symptoms of ischemic stroke |
5 Latvia Ischemic Stroke Market Trends |
6 Latvia Ischemic Stroke Market, By Types |
6.1 Latvia Ischemic Stroke Market, By Diagnosis |
6.1.1 Overview and Analysis |
6.1.2 Latvia Ischemic Stroke Market Revenues & Volume, By Diagnosis, 2021- 2031F |
6.1.3 Latvia Ischemic Stroke Market Revenues & Volume, By MRI, 2021- 2031F |
6.1.4 Latvia Ischemic Stroke Market Revenues & Volume, By Carotid Ultrasounds, 2021- 2031F |
6.1.5 Latvia Ischemic Stroke Market Revenues & Volume, By Cerebral Angiography, 2021- 2031F |
6.2 Latvia Ischemic Stroke Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Latvia Ischemic Stroke Market Revenues & Volume, By Tissue Plasminogen Activator, 2021- 2031F |
6.2.3 Latvia Ischemic Stroke Market Revenues & Volume, By Anticoagulant, 2021- 2031F |
6.2.4 Latvia Ischemic Stroke Market Revenues & Volume, By Antiplatelet, 2021- 2031F |
6.2.5 Latvia Ischemic Stroke Market Revenues & Volume, By Antihypertensive Source, 2021- 2031F |
7 Latvia Ischemic Stroke Market Import-Export Trade Statistics |
7.1 Latvia Ischemic Stroke Market Export to Major Countries |
7.2 Latvia Ischemic Stroke Market Imports from Major Countries |
8 Latvia Ischemic Stroke Market Key Performance Indicators |
8.1 Average time from symptom onset to treatment initiation |
8.2 Percentage of ischemic stroke patients receiving thrombolytic therapy within the recommended time window |
8.3 Number of healthcare providers trained in stroke recognition and management |
9 Latvia Ischemic Stroke Market - Opportunity Assessment |
9.1 Latvia Ischemic Stroke Market Opportunity Assessment, By Diagnosis, 2021 & 2031F |
9.2 Latvia Ischemic Stroke Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
10 Latvia Ischemic Stroke Market - Competitive Landscape |
10.1 Latvia Ischemic Stroke Market Revenue Share, By Companies, 2024 |
10.2 Latvia Ischemic Stroke Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |